Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells Govindaswami RagupathiLisa HowardPhilip O. Livingston ORIGINAL ARTICLE Pages: 1 - 8
A phase I study of a HER2/neu bispecific antibody with granulocyte-colony-stimulating factor in patients with metastatic breast cancer that overexpresses HER2/neu V. PullarkatY. DeoJ. S. Weber ORIGINAL ARTICLE Pages: 9 - 21
Lack of evidence for an immunosuppressive role for MUC1 Stéphane PaulNadine BizouarneR. Bruce Acres ORIGINAL ARTICLE Pages: 22 - 28
Production and characterization of an anti-(MUC1 mucin) recombinant diabody Graeme DentonKevin BradyMichael R. Price ORIGINAL ARTICLE Pages: 29 - 38
High frequency of T cell clonal expansions in primary human melanoma. Involvement of a dominant clonotype in autologous tumor recognition Patrizia PisarraRoberta MortariniMarialuisa Sensi ORIGINAL ARTICLE Pages: 39 - 46
Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls F. G. M. SnijdewintS. von Mensdorff-PouillyJ. Hilgers ORIGINAL ARTICLE Pages: 47 - 55
CD95 Ligand expression enhances growth of murine renal cell carcinoma in vivo Hiroaki NishimatsuTakumi TakeuchiTadaichi Kitamura ORIGINAL ARTICLE Pages: 56 - 61